Identity and Access Management Provider BIO-key to Participate at H.C. Wainwright Investment Conference in New York City, Sept. 11th & 12th

NEW YORK and WALL, N.J., Aug. 31, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions will participate at H.C. Wainwright’s 25^th Annual on Monday, September 11^th and Tuesday, September 12^th at the Lotte New York Palace Hotel in New York City. Bio-key’s CEO Mike DePasquale will be available for in-person investor meetings on Monday and Tuesday and for virtual meetings on Thursday Sept. 14th. BIO-key’s investor presentation will be available throughout the conference, starting Monday, September 11^th at 7:00 a.m. ET.

Please contact your H.C. Wainwright representative or Lily Khaykina at to schedule a meeting.

H.C. Wainwright & Co., LLC is a full-service investment bank providing Investment Banking, Equity Research, Sales & Trading, Corporate Access and Strategic Advisory services. will feature leading growth and technology companies from Monday, September 11^th through Wednesday, September 13^th.

About BIO-key International, Inc. ()

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software managing millions of users. Its cloud-based PortalGuard IAM solution provides cost-effective, easy to deploy, convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading Identity-Bound Biometric (IBB) capabilities, enable large-scale Identity-as-a-Service (IDaaS) solutions, as well as customized on premises solutions.

Investor Contacts

William Jones, David Collins

Catalyst IR

212-924-9800